Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Johnson' OR with Authors including 'Johnson' OR with Abstract including 'Johnson' OR with Keywords including 'Johnson'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Busch AK, Johnson WC L.S.D. 25 as an aid in psychotherapy Dis. Nerv. System 1950
Silva F, Heath RG, Raffer... Comparative effects of the administration of Taraxein, d-LSD, Mescalin... Comprehensive Psychi... 1960
F Silva, RG Heath, T Raff... Comparative effects of the administration of Taraxein, d-LSD, Mescalin... Compreh. Psychiat. 1960
AISENBERG AC, WILES B Studies on the supression of immune responses by the periwinkle alkalo... J Clin Invest 1964
Johnson FG LSD in the treatment of alcoholism Amer. J. Psychiat. 1969
Johnson FG A comparison of short-term treatment effects of intravenous sodium amy... Canad Psychiat Ass J 1970
Johnson DW, Gunn JW Dangerous drugs: adulterants, diluents, and deception in street sample... J Forensic Sci 1972
Kang S, Johnson CL, Green... Theoretical Studies on the Conformations of Psilocin and Mescaline Molecular Pharmacolo... 1973
Johnson BD Understanding British-addiction statistics Bulletin on Narcotic... 1975
Siva Sankar DV LSD-a Total Study   1975
Gallager DW, Aghajanian G... Effect of Antipsychotic Drugs on the Firing of Dorsal Raphe Cells I. R... Europ.J.Pharmacol. 1976
Kang S, Stzelczyk M, John... LSD Binding To Subcellular Fractions Of Rat Brain And Inhibitory Effec... Fed. Proc. 1976
Siegel RK, Brewster JM, J... The Effects of Hallucinogens On Blind Monkeys Intern.Pharmacopsych... 1976
Green JP, Johnson CL, Wei... Antagonism of histamine-activated adenylate cyclase in brain by D-lyse... Proc. Natl. Acad. Sc... 1977
Weinstein H, Johnson CL, ... Molecular Determinants For The Action Of Tryptamines On An LSD Recepto... Fed. Proc. 1977
Glennon RA, Martin B, Joh... 7,N,N-Trimethyltryptamine: a selective inhibitor of synaptosomal serot... Res Commun Chem Path... 1978
Green JP, Weinstein H, Ma... Defining the Histamine H2- Receptor in Brain: The Interaction With LSD QUASAR. Quantitative... 1978
Green JP, Johnson CL, Wei... Molecular Determinants For Interaction With The LSD Receptor: Biologic... Psychopharmacology o... 1978
North RA, Henderson G, Ka... Electrophysiological Evidence For Presynaptic Inhibition Of Acetycholi... Neuroscience 1980
Johnson MP, Hoffman AJ, N... Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... Eur J Pharmacol 1986
Stone DM, Johnson M, Hans... A comparison of the neurotoxic potential of methylenedioxyamphetamine ... Eur J Pharmacol 1987
Johnson M, Hanson GR, Gib... Effects of dopaminergic and serotonergic receptor blockade on neuroche... Neuropharmacology 1988
Johnson M, Letter AA, Mer... Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... J Pharmacol Exp Ther 1988
Stone DM, Johnson M, Hans... Role of endogenous dopamine in the central serotonergic deficits induc... J Pharmacol Exp Ther 1988
Johnson M, Hanson GR, Gib... Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... Eur J Pharmacol 1989
Johnson M, Stone DM, Bush... Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... Eur J Pharmacol 1989
Johnson MP, Nichols DE Neurotoxic effects of the alpha-ethyl homologue of MDMA following suba... Pharmacol Biochem Be... 1989
Nichols DE, Oberlender R,... Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA... Pharmacol Biochem Be... 1989
Stone DM, Johnson M, Hans... Acute inactivation of tryptophan hydroxylase by amphetamine analogs in... Eur J Pharmacol 1989
Gibb JW, Stone DM, Johnso... Role of dopamine in the neurotoxicity induced by amphetamines and rela... NIDA Res Monogr 1989
Hanson GR, Sonsalla P, Le... Effects of amphetamine analogs on central nervous system neuropeptide ... NIDA Res Monogr 1989
Herkenham M, Lynn AB, Lit... Cannabinoid receptor localization in brain Proc Natl Acad Sci U... 1990
Gibb JW, Johnson M, Hanso... Neurochemical basis of neurotoxicity Neurotoxicology 1990
Gibb JW, Johnson M, Stone... MDMA: historical perspectives Ann N Y Acad Sci 1990
Johnson MP, Huang XM, Obe... Behavioral, biochemical and neurotoxicological actions of the alpha-et... Eur J Pharmacol 1990
Nichols DE, Brewster WK, ... Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... J Med Chem 1990
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Callaway CW, Johnson MP, ... Amphetamine derivatives induce locomotor hyperactivity by acting as in... Psychopharmacology (... 1991
Huang XM, Johnson MP, Nic... Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) Eur J Pharmacol 1991
Johnson M, Bush LG, Gibb ... Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... Eur J Pharmacol 1991
Johnson MP, Conarty PF, N... [3H]monoamine releasing and uptake inhibition properties of 3,4-methyl... Eur J Pharmacol 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Johnson MP, Huang XM, Nic... Serotonin neurotoxicity in rats after combined treatment with a dopami... Pharmacol Biochem Be... 1991
Nichols DE, Johnson MP, O... 5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine Pharmacol Biochem Be... 1991
Steele TD, Brewster WK, J... Assessment of the role of alpha-methylepinine in the neurotoxicity of ... Pharmacol Biochem Be... 1991
Hanson GR, Bunker CF, Joh... Response of monoaminergic and neuropeptide systems to 4-methylaminorex... Eur J Pharmacol 1992
Elayan I, Gibb JW, Hanson... Long-term alteration in the central monoaminergic systems of the rat b... Eur J Pharmacol 1992
Johnson M, Elayan I, Hans... Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... J Pharmacol Exp Ther 1992
Johnson M, Mitros K, Ston... Effect of flunarizine and nimodipine on the decrease in tryptophan hyd... J Pharmacol Exp Ther 1992
Elayan I, Gibb JW, Hanson... Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymet... J Pharmacol Exp Ther 1993
Johnson M, Bush LG, Hanso... Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... Biochem Pharmacol 1993
Cohen ML, Johnson MP, Sch... DOI and alpha-methylserotonin: comparative vascular and nonvascular sm... J Pharmacol Exp Ther 1993
Che S, Johnson M, Hanson ... Body temperature effect on methylenedioxymethamphetamine-induced acute... Eur J Pharmacol 1995
Sprague JE, Johnson MP, S... Studies on the mechanism of p-chloroamphetamine neurotoxicity Biochem Pharmacol 1996
Gibb JW, Johnson M, Elaya... Neurotoxicity of amphetamines and their metabolites NIDA Res Monogr 1997
Hanson GR, Jensen M, John... Distinct features of seizures induced by cocaine and amphetamine analo... Eur J Pharmacol 1999
Johnson EA, Sharp DS, Mil... Restraint as a stressor in mice: against the dopaminergic neurotoxicit... Brain Res 2000
Golub A, Johnson BD, Sifa... Is the U.S. experiencing an incipient epidemic of hallucinogen use? Subst Use Misuse 2001
Johnson EA, Shvedova AA, ... d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxic... Brain Res 2002
Johnson EA, O'Callaghan J... Chronic treatment with supraphysiological levels of corticosterone enh... Brain Res 2002
Golub A, Johnson BD The misuse of the ‘Gateway Theory’ in US policy on drug abuse control:... International Journa... 2002
Kaye J, Buchanan F, Kendr... Acute carbon dioxide exposure in healthy adults: evaluation of a novel... J Neuroendocrinol 2004
Johnson EA, O\'Callaghan ... Brain concentrations of d-MDMA are increased after stress Psychopharmacology (... 2004
Johnson BD, Bardhi F, Sif... Marijuana Argot as Subculture Threads Birt J Criminol 2006
Kirsch I, Deacon BJ, Hued... Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data ... Public Library of Sc... 2008
Uhl GR, Liu QR, Drgon T, ... Molecular Genetics of Successful Smoking Cessation: Convergent Genome-... Arch Gen Psychiatry 2008
Griffiths RR, Richards WA... Mystical-type experiences occasioned by psilocybin mediate the attribu... J Psychopharm 2008
Johnson MW, Richards WA, ... Human hallucinogen research: guidelines for safety J Psychopharmacol. 2008
Bottorff JL, Johnson JL, ... Relief-oriented use of marijuana by teens Subst Abuse Treat Pr... 2009
Johnson PM, Kenny PJ Dopamine D2 receptors in addiction-like reward dysfunction and compuls... Nat Neurosci 2010
Johnson MW, Maclean KA, R... Human psychopharmacology and dose-effects of salvinorin A, a kappa opi... Drug Alcohol Depend 2010
Johnson LA, Johnson RL, A... Spice: a legal marijuana equivalent Mil Med 2011
MacLean KA, Johnson MW, G... Mystical experiences occasioned by the hallucinogen psilocybin lead to... J Psychopharmacol 2011
Griffiths RR, Johnson MW,... Psilocybin occasioned mystical-type experiences: immediate and persist... Psychopharmacology (... 2011
Reissig CJ, Carter LP, Jo... High doses of dextromethorphan, an NMDA antagonist, produce effects si... Psychopharmacology (... 2012
Johnson LA, Johnson RL, P... Current 'Legal Highs' J Emerg Med 2013
Johnson MW, Garcia-Romeu ... Pilot study of the 5-HT2AR agonist psilocybin in the treatment of toba... J Psychopharmacol 2014
Johnson MW, MacLean KA, C... Time course of pharmacokinetic and hormonal effects of inhaled high-do... J Psychopharmacol 2016
Liao Y, Tang J, Liu J, Xi... Decreased Thalamocortical Connectivity in Chronic Ketamine Users PLoS One 2016
Paul MJ, Chisolm MS, John... Assessing the Validity of Online Drug Forums as a Source for Estimatin... J Addict Med 2016
Carbonaro TM, Bradstreet ... Survey study of challenging experiences after ingesting psilocybin mus... J Psychopharmacol 2016
Johnson MW, Garcia-Romeu ... An online survey of tobacco smoking cessation associated with naturali... J Psychopharmacol 2017
Nichols DE, Johnson MW, N... Psychedelics as Medicines: An Emerging New Paradigm Clin Pharmacol Ther 2017
Saleemi S, Pennybaker SJ,... Who is 'Molly'? MDMA adulterants by product name and the impact of har... J Psychopharmacol 2017
Barrett FS, Johnson MW, G... Neuroticism is associated with challenging experiences with psilocybin... Personality and Indi... 2017
Carbonaro TM, Johnson MW,... Double-blind comparison of the two hallucinogens psilocybin and dextro... Psychopharmacology (... 2017
Davis AK, Clifton JM, Wea... Survey of entity encounter experiences occasioned by inhaled N,N-dimet... J Psychopharmacol 2020
Nicholas B.GiancolaBAClay... A “trip” to the ICU: intravenous injection of psilocybin Journal of the Acade... 2021